Next Generation Biosensors and Biodetection Technologies



July 19, 2012

  • Share
  • Jeff D Newman, Advanced Biosciences MSc Programme Director, Cranfield University

    The global diagnostics industry is dominated by the medical sector, which is very conservative and slow to adopt new technologies. The commercial attraction of the disposable strip concept is also undeniable. There have been improvements in ergonomics and the cost of meter manufacture has plummeted. Data storage and handling capabilities have also improved. Beyond this, though, the fundamental format has changed little for 25 years. The downside is that these devices only provide a “snapshot” measurement and they do not provide an alarm. Integration of components has provided ease of use. Modern devices often offer multiple glucose tests, multiple analytes, lancing combined with testing, testing combined with injectors and pumps combined with sensors. MiniMed introduced an implantable insulin pump in 1990. There are now several short-term implantable devices available for continuous monitoring. It is surely just a matter of time before a “closed-loop” system becomes available and the artificial pancreas becomes a reality. Possibly even more exciting, is the way in which consumer electronics have developed over recent years. The latest generations of mobile phones, miniature personal computer equipment, music players and other such technologies all have the capabilities in-built for biosensor integration technologies.

    DiagnosticsMass SpectrometryPersonalized Medicine

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.